Stay updated on KN026 in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the KN026 in Metastatic Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedThe last known status line now indicates Jiangsu Alphamab Biopharmaceuticals Co., Ltd as of September 2023, with status marked as Verified and Unknown.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Heilongjiang as a Location (Harbin, Heilongjiang, China) and removed the prior Heilongjiang Locations entry; page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision metadata now shows v3.3.2 as the current revision, replacing v3.3.1. No substantive content or study details appear to be affected.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedA broad government operations status notice was removed. The study details, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.4%

- Check67 days agoChange DetectedComparative screenshots show no substantive additions or deletions to the page content; only minor layout changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to KN026 in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 in Metastatic Breast Cancer Clinical Trial page.